Fibrinogen Concentrate (Human) and Insulin Degludec (U-100) Vials
Determining the interaction of Fibrinogen Concentrate (Human) and Insulin Degludec (U-100) Vials and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: fibrinogen
Brand name: RiaSTAP
Synonyms: Fibrinogen
Generic Name: insulin degludec
Brand name: Tresiba, Tresiba FlexTouch
Synonyms: Insulin degludec, Insulin Degludec
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Fibrinogen Concentrate (Human)-Insulin Degludec (U-200) Prefilled Pens
- Fibrinogen Concentrate (Human)-Insulin degludec and liraglutide
- Fibrinogen Concentrate (Human)-Insulin degludec and liraglutide Subcutaneous
- Fibrinogen Concentrate (Human)-Insulin degludec Subcutaneous
- Fibrinogen Concentrate (Human)-Insulin detemir
- Fibrinogen Concentrate (Human)-Insulin Detemir (Cartridges and Prefilled Syringes)
- Insulin Degludec (U-100) Vials-Fibrinogen Intravenous
- Insulin Degludec (U-100) Vials-Fibryga
- Insulin Degludec (U-100) Vials-Fidaxomicin
- Insulin Degludec (U-100) Vials-Filgrastim
- Insulin Degludec (U-100) Vials-Filgrastim Injection
- Insulin Degludec (U-100) Vials-Filgrastim, Tbo-filgrastim